[go: up one dir, main page]

BR9809914A - Genes de moracella receptores de lactoferrina - Google Patents

Genes de moracella receptores de lactoferrina

Info

Publication number
BR9809914A
BR9809914A BR9809914-0A BR9809914A BR9809914A BR 9809914 A BR9809914 A BR 9809914A BR 9809914 A BR9809914 A BR 9809914A BR 9809914 A BR9809914 A BR 9809914A
Authority
BR
Brazil
Prior art keywords
lactoferrin receptor
moraxella
genes
nucleic acid
proteins
Prior art date
Application number
BR9809914-0A
Other languages
English (en)
Inventor
Sheena M Loosmore
Michel H Klein
Run-Pan Du
Quijun Wang
Yang-Ping Yang
Original Assignee
Connaught Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26755908&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9809914(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/867,941 external-priority patent/US5977337A/en
Application filed by Connaught Lab filed Critical Connaught Lab
Publication of BR9809914A publication Critical patent/BR9809914A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

<B>GENES DE MORAXELLA RECEPTORES DE LACTOFERRINA<D> São fornecidas moléculas de ácido nucléico purificadas e isoladas, as quais codificam proteínas de moraxella receptoras de lactoferrina, como M. catarrhalis, ou então um fragmento ou análogo da proteína receptora de lactoferrina. A seq³ência de ácido nucléico pode ser utilizada para produzir proteínas receptoras de lactoferrina recombinantes Lbp1, Lbp2 ou ORF3 da cepa de Moraxella isentas de outras proteínas da cepa de Moraxella para fins de diagnóstico e tratamento médico. Além disso, a molécula de ácido nucléico pode ser utilizada no diagnóstico de infecção.
BR9809914-0A 1997-06-03 1998-06-02 Genes de moracella receptores de lactoferrina BR9809914A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/867,941 US5977337A (en) 1997-06-03 1997-06-03 Lactoferrin receptor genes of Moraxella
US09/074,658 US6184371B1 (en) 1997-06-03 1998-05-08 Lactoferrin receptor genes of Moraxella
PCT/CA1998/000544 WO1998055606A2 (en) 1997-06-03 1998-06-02 Lactoferrin receptor genes of moraxella

Publications (1)

Publication Number Publication Date
BR9809914A true BR9809914A (pt) 2001-09-18

Family

ID=26755908

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809914-0A BR9809914A (pt) 1997-06-03 1998-06-02 Genes de moracella receptores de lactoferrina

Country Status (8)

Country Link
EP (1) EP1000144B1 (pt)
JP (1) JP2001502925A (pt)
AT (1) ATE380867T1 (pt)
AU (1) AU739129B2 (pt)
BR (1) BR9809914A (pt)
CA (1) CA2292838A1 (pt)
NZ (1) NZ501911A (pt)
WO (1) WO1998055606A2 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU229968B1 (hu) 1999-03-19 2015-03-30 Smithkline Beecham Biologicals S.A Sztreptokokkusz oltóanyag
GB9914870D0 (en) * 1999-06-25 1999-08-25 Smithkline Beecham Sa Novel compounds
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
JP4740738B2 (ja) 2002-08-02 2011-08-03 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
RU2247373C2 (ru) * 2003-04-28 2005-02-27 Нижегородская государственная медицинская академия Способ экспресс-диагностики и дифференциальной диагностики урогенитальных инфекций
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
EA014107B1 (ru) 2005-12-22 2010-10-29 Глаксосмитклайн Байолоджикалс С.А. Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
CN104436180B (zh) 2006-01-17 2021-08-31 阿恩·福斯格伦 新的表面外露流感嗜血菌蛋白质(蛋白质E；pE)
US20100183662A1 (en) 2007-06-26 2010-07-22 Ralph Leon Biemans Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
GB201003922D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Conjugation process
CN102869377A (zh) 2010-03-10 2013-01-09 葛兰素史密丝克莱恩生物有限公司 免疫原性组合物
GB201103836D0 (en) 2011-03-07 2011-04-20 Glaxosmithkline Biolog Sa Conjugation process
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
IE87414B1 (en) 2017-05-30 2023-07-19 Glaxosmithkline Biologicals Sa Novel methods for manufacturing an adjuvant
CN111670044A (zh) 2017-12-01 2020-09-15 葛兰素史密丝克莱恩生物有限公司 皂苷纯化
WO2020030572A1 (en) 2018-08-07 2020-02-13 Glaxosmithkline Biologicals Sa Processes and vaccines
WO2020109365A1 (en) 2018-11-29 2020-06-04 Glaxosmithkline Biologicals Sa Methods for manufacturing an adjuvant
BR112021024363A2 (pt) 2019-06-05 2022-03-22 Glaxosmithkline Biologicals Sa Purificação de saponina
GB202205833D0 (en) 2022-04-21 2022-06-08 Glaxosmithkline Biologicals Sa Bacteriophage
EP4558170A1 (en) 2022-07-19 2025-05-28 GlaxoSmithKline Biologicals S.A. Continuous process for vaccine production

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
JP3335622B2 (ja) * 1989-04-27 2002-10-21 ユニバーシティ テクノロジーズ インターナショナル インコーポレイテッド 細菌からトランスフェリン及びラクトフェリン受容体タンパク質を分離及び精製する方法並びにこれらを含有するワクチンを調製する方法
US6048539A (en) * 1995-11-02 2000-04-11 Connaught Laboratories Limited Lactoferrin receptor protein

Also Published As

Publication number Publication date
EP1000144A2 (en) 2000-05-17
ATE380867T1 (de) 2007-12-15
CA2292838A1 (en) 1998-12-10
AU739129B2 (en) 2001-10-04
NZ501911A (en) 2001-12-21
AU7753498A (en) 1998-12-21
WO1998055606A3 (en) 1999-03-04
JP2001502925A (ja) 2001-03-06
WO1998055606A2 (en) 1998-12-10
EP1000144B1 (en) 2007-12-12

Similar Documents

Publication Publication Date Title
BR9809914A (pt) Genes de moracella receptores de lactoferrina
McGavin et al. Fibronectin binding determinants of the Staphylococcus aureus fibronectin receptor
GR900100716A (el) C3B/C4B υποδοχέας (CR1).
AR008588A1 (es) Molecula de acido nucleico aislada que hibridiza con un gen de saliva de pulga, proteina aislada codificada por dicha molecula, composicion terapeuticapara tratar la dermatitis alergica, kit de ensayo para determinar dicha dermatitis, molecula, virus y celula recombinantes, y anticuerpo aislado
DE68929466D1 (de) Menschlicher rezeptor c3b/c4b (cr1)
ATE338113T1 (de) Transferrin-rezeptor gene von haemophilus
RU2227743C2 (ru) Полипептидные варианты с повышенной гепаринсвязывающей способностью
AR002742A1 (es) Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn
BR9608482A (pt) Genes receptores de transferrina
ATE315787T1 (de) Methoden zur identifizierung von modulatoren wechselwirkender proteine
RU2010120571A (ru) Тимус-специфический белок
MD20000034A (ro) Proteinele virusului răsucirii frunzelor de viţă de vie (tipul 2) şi utilizarea lor
RU2214273C2 (ru) ДНК-ПОСЛЕДОВАТЕЛЬНОСТИ, КОДИРУЮЩИЕ ЧЕЛОВЕЧЕСКИЕ ПРОТЕИНЫ Tx И Ty, РОДСТВЕННЫЕ КОНВЕРГИРУЮЩЕМУ ИНТЕРЛЕЙКИН-1-β ФЕРМЕНТУ
EP0261403A3 (de) Polypeptide des Rhinovirusstammes HRV89 sowie die hierfür codierenden DNA-Moleküle
AR029627A1 (es) Derivados de proteina c y composiciones farmaceuticas formuladas con dichos derivados, moleculas de dna recombinante que codifican dichos derivados; vectores de transformacion que comprenden dichos derivados; aislados de acidos nucleicos que comprenden polinucleotidos que codifican al menos el 90% d
WO2004085461A3 (de) An mhc-moleküle bindende tumor-assoziierte peptide
EP1905831A3 (en) Lactoferrin receptor genes of moraxella
AR025482A1 (es) Secuencia de adn que codifica una proteina capaz de ligarse a traf; vector que comprende dicha secuencia; celulas huespedes transformadas con dicho vector;proteinas iren codificadas por dicha secuencia; metodo para producir dicha proteina; anticuerpos especificos para dichas proteinas; metodo para m
BR9713540A (pt) Procedimento para a expressão do gene do vìrus da dengue
BR9909576A (pt) Genes de receptor de transferrina de moraxella
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
DK0811068T3 (da) Humane DNase I varianter
ATE278011T1 (de) Human dnase ii
YU8395A (sh) Protein sa tpo aktivnošću
DE69925927D1 (de) Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. PORTANTO, INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO - DE ACORDO COM O ART. 8O DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.